HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Sulfamoxole
A sulfanilamide antibacterial agent.
Also Known As:
Sulphamoxole; Benzenesulfonamide, 4-amino-N-(4,5-dimethyl-2-oxazolyl)-
Networked:
9
relevant articles (
2
outcomes,
0
trials/studies)
Relationship Network
Bio-Agent Context: Research Results
Organic Chemicals: 133
Amines: 4871
Aniline Compounds: 46
Sulfanilamides: 40
Sulfamoxole: 9
trimethoprim drug combination sulfamoxole: 16
Amides: 2428
Sulfonamides: 2809
Benzenesulfonamides: 153
Sulfamoxole: 9
trimethoprim drug combination sulfamoxole: 16
Sulfanilamides: 40
Sulfamoxole: 9
trimethoprim drug combination sulfamoxole: 16
Hydrocarbons: 1713
Cyclic Hydrocarbons: 97
Aromatic Hydrocarbons: 291
Benzene Derivatives: 17
Benzenesulfonamides: 153
Sulfamoxole: 9
trimethoprim drug combination sulfamoxole: 16
Sulfur Compounds: 278
Sulfones: 534
Sulfonamides: 2809
Benzenesulfonamides: 153
Sulfamoxole: 9
trimethoprim drug combination sulfamoxole: 16
Sulfanilamides: 40
Sulfamoxole: 9
trimethoprim drug combination sulfamoxole: 16
Related Diseases
1.
Bacterial Infections (Bacterial Infection)
01/01/1976 - "
The following conclusions emerged from an analysis of the therapeutic results documented during the clinical trial of N1-(4,5-dimethyl-2-oxazolyl)-sulfanilamide (sulfamoxole) and 2,4-diamino)-5-(3,4,5-trimethoxy-benzyl)-pyrimidine (trimethoprim) (CN 3123, Nevin, Supristol) in bacterial infections of the respiratory tract and ENT organs: 1. In bacterial infections of the bronchopulmonary system, the antibacterial activity of CN 3123 was demonstrated in 94% of the patients, in that 75% of patients were cured and there was a definite improvement in 19%.
"
01/01/1976 - "
During the clinical trial of N1-(4,5-dimethyl-2-oxazolyl)-sulfanilamide (sulfamoxole) and 2,4-diamino-5-(3,4,5-trimethoxy-benzyl)-pyrimidine (trimethoprim) (CN 3123, Nevin, Supristol) results from 925 treated cases of bacterial infections of the urinary organs were documented.
"
01/01/1976 - "
The antibacterial activity of N1-(4,5-dimethyl-2-oxazolyl)-sulfanilamide (sulfamoxole) and 2,4-diamino-5-(3,4,5-trimethoxy-benzyl)-pyrimidine (trimethoprim) (CN 3123, Nevin, Supristol) was studied in various bacterial infections in the fields of internal medicine, dermatology and gynecology.
"
2.
Infections
02/01/1962 - "
Sulfamoxole in respiratory allergy associated with infection.
"
01/01/1976 - "
The experimental infections of the mouse by gram-positive and gram-negative germs are effectively treated with the combination of N1-(4,5-dimethyl-2-oxazolyl)-sulfanilamide (sulfamoxole) and 2,4-diamino-5-(3,4,5-trimethoxy-benzyl)-pyrimidine (trimethoprim) (CN 3123, Nevin, Supristol).
"
3.
Urinary Tract Infections (Urinary Tract Infection)
04/01/1976 - "
[Management of urinary tract infections in gynecologic patients with a new combination of sulfamoxole and trimethoprim].
"
4.
Urethritis
05/01/1962 - "
Sulfamoxole (Nuprin) in the treatment of non-gonococcal urethritis and other conditions.
"
5.
Ulcer
07/01/1985 - "
Trimethoprim alone in a dose of 700 mg or the combination of sulphamoxole (3200 mg) and trimethoprim (640 mg) is not satisfactory for the single dose treatment of genital ulcer disease.
"
Related Drugs and Biologics
1.
trimethoprim drug combination sulfamoxole
2.
Trimethoprim (Proloprim)
3.
Ibuprofen (Motrin)